# Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

> **NCT01772771** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 12000 (estimated)

## Conditions studied

- Glioma
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Melanoma
- Sarcoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Genetic Testing
- **OTHER:** Medical Chart Review

## Key facts

- **NCT ID:** NCT01772771
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2012-03-01
- **Primary completion:** 2032-03-01
- **Final completion:** 2033-03-01
- **Target enrollment:** 12000 (ESTIMATED)
- **Last updated:** 2026-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772771, "Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01772771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*